Stock Earnings

Question 1

What are Senti Biosciences Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Senti Biosciences Inc has a total asset of $97, Net loss of $-52

Question 2

What are the key financial ratios for SNTI?

Accepted Answer

Senti Biosciences Inc's Current ratio is 2.06, has a Net margin is 0, sales per share of $0.

Question 3

How is Senti Biosciences Inc's revenue broken down by segment or geography?

Accepted Answer

Senti Biosciences Inc largest revenue segment is Next-generation Cell and Gene Therapies, at a revenue of 2,561,000 in the most earnings release.For geography, United States is the primary market for Senti Biosciences Inc, at a revenue of 2,561,000.

Question 4

Is Senti Biosciences Inc profitable?

Accepted Answer

no, according to the latest financial statements, Senti Biosciences Inc has a net loss of $-52

Question 5

Does Senti Biosciences Inc have any liabilities?

Accepted Answer

yes, Senti Biosciences Inc has liability of 47

Question 6

How many outstanding shares for Senti Biosciences Inc?

Accepted Answer

Senti Biosciences Inc has a total outstanding shares of 4.82

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	2	4	2	0
Revenue Growth (YoY)	--	-100%	-50%	100%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	25	23	37	38	21	9
Research & Development	37	34	32	28	21	15
Operating Expenses	66	60	69	66	43	25
Other Non Operating Income (Expenses)	4	-6	6	9	-14	5
Pretax Income	-47	-52	-83	-49	-55	-19
Income Tax Expense	0	--	--	--	--	--
Net Income	-47	-52	-71	-58	-55	-19
Net Income Growth	-33%	-27%	22%	5%	189%	-10%
Shares Outstanding (Diluted)	26.22	4.59	4.43	4.4	4.36	4.36
Shares Change (YoY)	473%	4%	1%	1%	0%	0%
EPS (Diluted)	-1.81	-11.49	-16.01	-13.21	-12.67	-4.55
EPS Growth	-88%	-28%	21%	4%	178%	-6%
Free Cash Flow	-50	-41	-64	-76	-40	-25
Free Cash Flow Per Share	-1.9	-8.92	-14.42	-17.24	-9.16	-5.72
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	-3,300%	-1,550%	-2,000%	0%
Profit Margin	0%	0%	-3,550%	-1,450%	-2,750%	0%
Free Cash Flow Margin	0%	0%	-3,200%	-1,900%	-2,000%	0%
EBITDA	-63	-57	-63	-61	-40	-24
EBITDA Margin	0%	0%	-3,150%	-1,525%	-2,000%	0%
D&A For EBITDA	3	3	3	1	0	0
EBIT	-66	-60	-66	-62	-40	-24
EBIT Margin	0%	0%	-3,300%	-1,550%	-2,000%	0%
Effective Tax Rate	0%	--	--	--	--	--

Senti Biosciences Inc (SNTI) Price

SNTI Stock Price Chart

SNTI Income

Follow-Up Questions